CagriTirz

CagriTirz 10mg/10mg is a peptide blend designed to support weight loss and metabolic health.

CagriTirz

What is CagriTirz?

CagriTirz is a peptide blend combining Cagrilintide and Tirzepatide, two compounds known for their weight loss and metabolic benefits. This blend is designed to enhance fat loss, improve glucose control, and support overall metabolic health in research settings.

How It Works (Mechanism of Action)

CagriTirz combines the effects of Cagrilintide (an amylin receptor agonist) and Tirzepatide (a GLP-1 and GIP receptor agonist). Cagrilintide reduces appetite and slows gastric emptying, while Tirzepatide enhances insulin secretion and reduces glucagon levels, leading to improved glucose control and fat loss.

Potential Benefits & Use Cases

• Weight Loss: Dual action for enhanced appetite suppression and fat reduction.
• Metabolic Health: Improves insulin sensitivity and glucose regulation.
• Obesity Research: Studied for its synergistic effects in obesity management.

Typical Dosage & Administration

Administration: Subcutaneous injection.

Dosage:

• Typical doses range from 1 mg to 2.5 mg of each peptide per week.
• Often administered once weekly, with gradual dose escalation.

Possible Side Effects

• Nausea: Common during initial use, typically subsides.
• Injection Site Reactions: Mild redness or irritation.
• Gastrointestinal Discomfort: Possible bloating or diarrhea.

Other Relevant Details

• Combines the benefits of Cagrilintide and Tirzepatide for enhanced efficacy.
• Under investigation for optimal dosing and long-term safety.